Mixed trend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since May 27 · inside the Ichimoku cloud · RSI 0 (oversold) · MACD above its signal · at its 52-week high
None of the 29 investors followed here reported a position in OWCP in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a OWCP trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for OWCP.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −90.0% |
| 2024 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2023 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2022 | 200.0 | -66.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2021 | 20.0 | 29.4 | -12.9 | -5.7 | -16.1 | 1.1 | -18.5 | -25.3 | -92.9 | 100.0 | -87.5 | 0.0 | −98.8% |
| 2020 | -36.1 | -35.1 | -56.1 | -40.7 | 9.4 | 6.2 | -11.2 | -11.1 | -11.4 | -3.8 | 33.3 | -15.0 | −90.4% |
| 2019 | -2.4 | -60.2 | -15.4 | -36.8 | -10.7 | -15.4 | -29.2 | -34.8 | 37.3 | -17.5 | -30.6 | 1408.5 | −14.0% |
| 2018 | -5.5 | -16.2 | -33.1 | 0.8 | -3.3 | -0.9 | -38.4 | 33.7 | -10.2 | -12.9 | 6.5 | -35.3 | −77.2% |
| 2017 | 240.3 | 337.4 | -57.6 | -13.5 | -25.0 | -13.9 | -48.0 | -6.9 | 26.7 | -14.5 | 47.4 | -5.1 | +158.3% |
| 2016 | 133.3 | 42.9 | -2.5 | -48.7 | 0.0 | -70.0 | 33.3 | 19.5 | -54.8 | 1474.1 | -35.3 | 60.0 | +486.7% |
| 2015 | 14.6 | -9.1 | 25.0 | 6.7 | -28.8 | 21.0 | -13.0 | -19.0 | -7.4 | -33.3 | -10.0 | -66.7 | −84.4% |
| 2014 | -29.1 | 500.0 | 350.0 | 10.7 | -9.7 | -11.1 | 20.8 | -8.6 | 1.8 | -33.3 | 19.4 | -10.7 | +1261.7% |
| 2013 | 0.0 | 75.0 | 27.9 | -38.5 | 152.3 | 15.3 | -12.5 | -2.0 | -70.5 | -50.6 | -50.0 | -29.5 | −82.4% |
| 2012 | -35.0 | 169.2 | 0.0 | 0.0 | -60.0 | 71.4 | 0.0 | -45.8 | 0.0 | -38.5 | 161.9 | -61.8 | −60.0% |
| 2011 | 0.0 | 29.4 | 0.0 | -31.8 | 80.0 | 7.4 | 100.0 | 36.2 | -17.7 | -23.1 | -36.0 | -37.5 | +17.6% |
| 2010 | -25.0 | 0.0 | 46.7 | -63.6 | -25.0 | 66.7 | -58.0 | -14.3 | 66.7 | 50.0 | -33.3 | -43.3 | −83.0% |
| 2009 | 0.0 | -62.5 | -66.7 | −87.5% |
No analyst coverage for this instrument.
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.
No recent headlines.